FDA classifies ultrasound device for nerve blocks as lower risk
/ 1 min read
Table of Contents
The Food and Drug Administration has officially classified a specific type of medical device used during regional anesthesia procedures. The agency placed the ScanNav Anatomy Peripheral Nerve Block device into Class II, which means it carries moderate to low risk but requires special controls to ensure safety.
Why it matters: This action primarily affects medical device manufacturers by streamlining how they get this specific technology to market. It also impacts healthcare providers who may find it easier to access devices that help with nerve block procedures, potentially improving precision in pain management and surgical anesthesia. For patients, the change is administrative but suggests a pathway for safer, more accessible tools without compromising safety standards.
Who it affects
- Manufacturers of real-time ultrasound anatomy visualization and labeling devices
This information comes from a final order issued by the Food and Drug Administration in the Federal Register; you should check the original document for full regulatory text before relying on it.
Agency: Health and Human Services Department, Food and Drug Administration
Source: Federal Register — read the official document